Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4800
-0.0200 (-4.00%)
Jan 22, 2026, 1:04 PM EST - Market open
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $50.22 million as of January 22, 2026. Its market cap has increased by 183.46% in one year.
Market Cap
50.22M
Enterprise Value
75.18M
1-Year Change
183.46%
Ranking
Category
Stock Price
$0.48
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $50.22M, an increase of 45.59%. That is a compound annual growth rate of 32.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 48.00M | -9.15% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 52.26M |
| iBio, Inc. | 51.95M |
| Aligos Therapeutics | 51.81M |
| NeurAxis | 51.56M |
| ABVC BioPharma | 49.50M |
| Lite Strategy | 49.46M |
| Q32 Bio | 49.24M |
| Instil Bio | 48.83M |